Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Pharmacological Study of Pemetrexed Administered With Cisplatin and a Vitamin Supplement in Patients With Nonresectable Pleural Mesothelioma

NCT00541073 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT00541073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00541073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Pharmacological Study of Pemetrexed Administered With Cisplatin and a Vitamin Supplement in Patients With Nonresectable Pleural Mesothelioma
Lead sponsor
Centre Oscar Lambret
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
Not reported
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant mesothelioma